In a study on colorectal cancer mice, DNase I degraded NETs induced by tumor cells, suppressing NETs-created resistance to anti-PD-1 blockade by increasing CD8+ T-cell infiltration and cytotoxicity. Here, CD8A is linked to neoplasm.